-
Notice to the Market About Petrobras Global Offer
RIO DE JANEIRO, Sept. 4 /PRNewswire-Asia/ -- Petrobras (BM&FBOVESPA: PETR3; PETR4) has informed that this Friday (Sept. 3) it filed with the Comissao de Valores Mobiliarios, the Brazilian securities regulator or CVM, a Public Offering request for primary distribution of 2,174,073,900 new common shares and 1,585,867,988 new preferred shares, to take place simultaneously in Brazil and abroad.
Click here (http://www.agenciapetrobrasdenoticias.com.br/upload/apresentacoes/apresentacao_i973oQaHmq.pdf) to read the Prospectus.
INFORMATION, PHOTOS, AUDIO AND VIDEO RECORDINGS AT HTTP://WWW.PETROBRASNEWSAGENCY.COM .
-
China Sky One Medical Updates Financial Guidance for 2010
HARBIN, China, Sept. 4 /PRNewswire-Asia/ -- China Sky One Medical, Inc. ("China Sky One Medical" or "the Company") (Nasdaq: CSKI), a leading fully integrated pharmaceutical company in the People's Republic of China ("PRC"), today announced that its fiscal year 2010 revenue and adjusted net income, excluding the impact of derivative warrant liabilities, are expected to be lower than its previous financial guidance as a result of the termination of several major distributor relationships.
Specifically, the Company has lowered its 2010 revenue guidance from a prior range of $160 million and $164 million to between $128 million and $136 million. The Company also has lowered its 2010 adjusted net income guidance, excluding the impact of derivative warrant liabilities, from between $40 million and $41 million to between $26 million and $31 million.
Management's reduced guidance reflects the termination of relationships with certain private distributors, who after several rounds of discussions, chose to end their cooperation with the Company after learning that their business information was disclosed in the Company's public SEC filings and would continue to be disclosed in such documents as required by SEC regulations. This disclosure, these distributors claim, has led to increased scrutiny of their financial performance by government authorities within China. While the Company expects to replace these lost distribution arrangements over time, revenue and net income in the second half of 2010 are expected to be negatively impacted by the disruption in distribution channels. The Company expects to incur higher selling and marketing costs during second half 2010 to develop new distributor relationships.
Separately, the Company announced the resignation of its CFO, Mr. Stanley Hao, due to health considerations, effective September 01, 2010. Mr. Hao will retain his position as Company Director and Board Secretary. Mr. Yu-kun Zhang, the Company's Principal Financial and Accounting Officer, will continue to oversee the accounting and finance functions, while the Company actively searches for a new CFO.
"We are disappointed with the decision by several of our larger distributors to end their cooperation with China Sky One," commented Mr.
Yan-Qing Liu, Chairman and CEO of China Sky One Medical. "We expect to recoup this lost business over time by building new relationships with reputable provincial and national distributors. In addition, we want to thank Stanley Hao for his contributions as Chief Financial Officer and look forward to his continued contributions in a role that will allow him to address his health issues. We are actively seeking a qualified successor with a strong background in US GAAP accounting and the capital markets to provide effective leadership for our finance team and support China Sky One's future expansion."
About China Sky One Medical, Inc.
China Sky One Medical, Inc., a Nevada corporation, is a holding company. The Company engages in the manufacturing, marketing and distribution of pharmaceutical, medicinal and diagnostic products. Through its wholly-owned subsidiaries, Harbin Tian Di Ren Medical Science and Technology Company ("TDR"), Harbin First Bio-Engineering Company Limited ("First"), Heilongjiang Tianlong Pharmaceutical, Inc. ("Tianlong") and Peng Lai Jin Chuang Pharmaceutical Company ("Jin Chuang") the Company manufactures and distributes over-the-counter pharmaceutical products, which make up its major revenue source. For more information, visit http://www.cski.com.cn .
Safe Harbor Statement
Certain of the statements made in the press release constitute
forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. These statements can be identified by the use of forward- looking terminology such as "believe," "expect," "may," "will," "should," "project," "plan," "seek," "intend," or "anticipate" or the negative thereof or comparable terminology. Such statements typically involve risks and uncertainties and may include financial projections or information regarding the Company's termination with above mentioned ex-customers and update of financial guidance for 2010, as well as Mr. Stanley Hao's resignation as the Company's CFO. Actual results could differ materially from the expectations reflected in such forward-looking statements as a result of a variety of factors, including the risks associated with the effect of changing economic conditions in The People's Republic of China, variations in cash flow, reliance on collaborative retail partners and on new product development, variations in new product development, risks associated with rapid technological change, and the potential of introduced or undetected flaws and defects in products, and other risk factors detailed in reports filed with the Securities and Exchange Commission from time to time.
-
Longwei Petroleum to Present at the Rodman & Renshaw Annual Global Investment Conference
TAIYUAN CITY, China, Sept. 4 /PRNewswire-Asia/ -- Longwei Petroleum Investment Holding Limited (NYSE Amex: LPH) ("Longwei" or the "Company"), an energy company engaged in the storage and distribution of oil and gas in the People's Republic of China ("PRC"), announced today that the Company will present at the Rodman & Renshaw Annual Global Investment Conference, being held September 12-15, 2010 in New York City. Presentation details are provided below:
Date: Tuesday, September 14, 2010
Time: 9:10 a.m. EDT
Location: The Louis Salon (4th floor)
The New York Palace Hotel
Longwei will also be available for one-on-one meetings with investors. To schedule a meeting with Longwei at this event or in the New York area, call Jon Cunningham at 407-644-4256, Ext. 107, or email info@redchip.com. For more information about the conference, visit http://www.rodmanrenshaw.com .
About Longwei Petroleum Investment Holding Limited
Longwei Petroleum Investment Holding, Limited (the "Company") is an energy company that, through its subsidiaries, engages in oil and gas operations in the People's Republic of China ("PRC"). Oil and gas operations consist of transporting, marketing and selling finished petroleum products. The Company's headquarters and primary facilities are located in Taiyuan City, Shanxi Province ("Shanxi"). The Company's second facility is located in Gujiao, Shanxi. The Company purchases diesel, gasoline, fuel oil and kerosene (the "Products") from various petroleum refineries in the PRC. The Company is 1 of 3 licensed intermediaries in Taiyuan City and the sole licensed intermediary in Gujiao that operates its own large scale storage tanks. The Company has the necessary licenses to operate and sell Products not only in Shanxi but throughout the entire PRC. The Company's storage tanks have the largest storage capacity of any non-government operated entity in Shanxi. The Company seeks to earn profits by selling its Products at competitive prices to
large-scale gas stations, coal plants, other power-supply customers and small, independent gas stations. The Company also earns revenue by acting as a purchasing agent for other intermediaries in Shanxi and through the sale of diesel and gasoline at gas stations located at each of the Company's facilities. The sales price and the cost basis of the Company's products are largely dependent on regulations and price control measures instituted and controlled by the PRC government as well as the price of crude oil. The price of crude oil is subject to fluctuation due to a variety of factors, all of which are beyond the Company's control.
For further information on Longwei Petroleum Investment Holding Limited, please visit http://www.longweipetroleum.com . You may register to receive Longwei Petroleum Investment Holding Limited's future press releases or request to be added to the Company's distribution list by contacting Dave Gentry at info@redchip.com.
Forward-Looking Statements
Certain statements contained herein constitute "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995. These forward-looking statements are based on current expectations, estimates and projections about Longwei's industry, management's beliefs and certain assumptions made by management. Readers are cautioned that any such forward-looking statements are not guarantees of future performance and are subject to certain risks, uncertainties and assumptions that are difficult to predict. Because such statements involve risks and uncertainties, the actual results and performance of the Company may differ materially from the results expressed or implied by such forward-looking statements. Given these uncertainties, readers are cautioned not to place undue reliance on such forward-looking statements. Longwei's operations are conducted in the PRC and, accordingly, are subject to special considerations and significant risks not typically associated with companies in North America and Western Europe. These include risks associated with, among others, the political, economic and legal environment and foreign currency exchange. The Company's results may be adversely affected by changes in the political and social conditions in the PRC and by changes in governmental policies with respect to laws and regulations, anti-inflationary measures, currency conversion, remittances abroad, and rates and methods of taxation. Other potential risks and uncertainties include but are not limited to the ability to procure, properly price, retain and successfully complete projects, and changes in products and competition. Unless otherwise required by law, the Company also disclaims any obligation to update its view of any such risks or uncertainties or to announce publicly the result of any revisions to the forward-looking statements made here. Readers should review carefully reports or documents the Company files periodically with the Securities and Exchange Commission.
-
China-Biotics Announces September 20 Investor Day Schedule
SHANGHAI, Sept. 4 /PRNewswire-Asia/ -- China-Biotics, Inc. ("China-Biotics", the "Company") (Nasdaq: CHBT), the leading developer, manufacturer and distributor of probiotics products in China, today announced the schedule for the Investor Day, which will be held on Monday, September 20, 2010, in Shanghai.
Event schedule
07:15 a.m. Hotel pick-up and transport to the Pudong facility located in
Jinqiao Industrial Park
08:30 a.m. Management presentation and Q&A
09:30 a.m. Distributors' speech and Q&A
10:00 a.m. Pudong facility tour
10:30 a.m. Depart for retail outlets tour
12:00 p.m. Working lunch
12:30 p.m. Continue retail outlets tour
14:30 p.m. Bulk additives facility tour at Qingpu Industrial Park
15:15 p.m. Bulk additives customers' speech
15:35 p.m. R&D director speech and Q&A
16:00 p.m. Chairman's speech on bulk strategy plan and closing remarks
for Investor Day
17:00 p.m. Transportation back to the hotel
The Company has secured a reservation for a large number of single occupancy rooms at an internationally branded hotel in the Bund area using a corporate discount rate. Detailed information of the hotel accommodation will be distributed later today to event participants who have completed their reservations.
About China-Biotics
China-Biotics, Inc. ("China-Biotics," the "Company"), a leading manufacturer of biotechnology products and supplements, engages in the research, development, marketing and distribution of probiotics dietary supplements in China. Through its wholly owned subsidiaries, Shanghai Shining Biotechnology Co., Ltd. and Growing Bioengineering (Shanghai) Co. Ltd., the Company develops and produces its proprietary product portfolio. Currently, the retail products are sold OTC through large distributors to pharmacies and supermarkets in Shanghai, Jiangsu, and Zhejiang province. The company currently sells bulk products to institutional customers such as dairy and animal feed producers, as well as pharmaceutical companies. In February 2010, China-Biotics began its commercial production in China's largest probiotics production facility to meet growing demand in China. For more information, please visit http://www.chn-biotics.com .
-
/C O R R E C T I O N - Mindray Medical International Limited /
In the news release, "Mindray Medical to Present at the Goldman Sachs 7th Annual European Medtech and Healthcare Services Conference," issued Wednesday, August 25, by Mindray Medical International Limited (NYSE: MR) over PR Newswire Asia, we are advised by the company that Mr. Ronald Ede, instead of both Mr. Ronald Ede and Mr. Minghe Cheng, will attend the Goldman Sachs 7th Annual European Medtech and Healthcare Services Conference, as originally issued inadvertently. The complete, corrected release follows.
Mindray Medical to Present at the Goldman Sachs 7th Annual European Medtech and Healthcare Services Conference
SHENZHEN, China, Aug. 25 /PRNewswire-Asia-FirstCall/ -- Mindray Medical International Limited (NYSE: MR), a leading developer, manufacturer and marketer of medical devices worldwide, today announced that it will present at the Goldman Sachs 7th Annual European Medtech and Healthcare Services Conference in London on September 8th, 2010. Mr. Ronald Ede will present on behalf of Mindray.
The Goldman Sachs 7th Annual European Medtech and Healthcare Services Conference will be attended by Mr. Ronald Ede, Mindray's chief financial officer. The conference will take place at Goldman Sachs' offices, located at 120 Fleet Street in London, UK, from Wednesday, September 8th to Thursday, September 9th, 2010. Mr. Ronald Ede will present on Wednesday, September 8th at 01:45 pm GMT.
About Mindray
We are a leading developer, manufacturer and marketer of medical devices worldwide. We maintain our global operational headquarters in Shenzhen, China, and multiple sales offices in major domestic and international markets. From our main manufacturing and engineering base in China and through our worldwide distribution network, we supply internationally a broad range of products across three primary business segments, comprised of patient monitoring and life support products, in-vitro diagnostic products and medical imaging systems. For more information, please visit http://ir.mindray.com.
-
Large Insider Trades Found in Atmel, Baker Hughes, Amgen, First Solar, Human Genome Sciences, & Aruba; Reported by Insiderslab.com
VANCOUVER, Canada, Sept. 3 /PRNewswire-Asia/ -- Insiderslab.com issues new research reports that highlight large insider trades found in for Atmel, Baker Hughes, Amgen, First Solar, Human Genome Sciences, & Aruba. Read our research reports with Interactive Insider Trading Charts and Insider Trade Statistics below.
Insiders refer to company Top Executive Officers (CEOs, CFOs, COOs) and Directors who are involved in making critical corporate decisions.
(Read full report by clicking the links, you may need to copy and paste the full link to your browser.)
Atmel Corp.: Open-market Purchase made by company Directors on Aug 31st, at trade price (US$5.87). Disclose date: Sep 1st. Read Full Report: http://www.insiderslab.com/PR/090310B/ATML/Atmel (NASDAQ: ATML)
Baker Hughes Inc.: Open-market Sale made by company C-Level Officers on Sep 1st, at trade price (US$39.10). Disclose date: Sep 2nd. Read Full Report: http://www.insiderslab.com/PR/090310B/BHI/Baker-Hughes (NYSE: BHI)
Amgen Inc.: Open-market Sale made by company C-Level Officers on Aug 30th, at trade price (US$52.34). Disclose date: Aug 31st.Read Full Report: http://www.insiderslab.com/PR/090310B/AMGN/Amgen (NASDAQ: AMGN)
First Solar, Inc.: Market Option Sale made by company C-Level Officers on Aug 30th, at trade price (US$126.98). Disclose date: Sep 1st. Read Full Report: http://www.insiderslab.com/PR/090310B/FSLR/First-Solar (NASDAQ: FSLR)
Human Genome Sciences Inc.: Market Option Sale made by company C-Level Officers on Sep 1st, at trade price (US$30.02). Disclose date: Sep 2nd. Read Full Report:
http://www.insiderslab.com/PR/090310B/HGSI/Human-Genome-Sciences (NASDAQ: HGSI)
Aruba Networks, Inc.: Open-market Sale made by company C-Level Officers on Aug 30th, at trade price (US$18.17). Disclose date: Aug 31st. Read Full Report: http://www.insiderslab.com/PR/090310B/ARUN/Aruba (NASDAQ: ARUN)
There are thousands of insider filings on the stock markets every day. Insiderslab.com strives to turn this massive raw data into usable information that investors can use to do better research for their investments. Today Insiderslab.com issues new research reports on large insider trades found in the above Blue Chips or Penny Stock companies.
Subscribe for FREE insider trading alert newsletters that track all the stocks on the OTCBB, NASDAQ, SP500, DOWJ, and NYSE. Click here: http://www.insiderslab.com .
Every day, Insiderslab.com research analysts spend hours to track and monitor insider trading activities in the U.S. markets and issue Insider Trading Research Reports every day. Watch the next report tomorrow for one of the following research highlights:
1. Down by Half Purchases made by C-Level officers, Directors, and 10%
shareholders
2. Large purchases/sales made by C-Level officers
3. Large insiders sales at 52-week highs
4. Large insider purchases at 52-week lows
5. Consensus purchase/sales by a group of insiders
About Insiderslab.com:
Insiderslab.com is a leading provider of independent reports on insider trade. Its services include insider trade statistics reported on blue chips and penny stocks, real-time insider trading alerts on insider transactions, and newsletters on notable insider trades. Insiderslab.com is composed of a team of experienced analysts who strive to provide the investment community with the software and data necessary to carry investment research. Insiderslab.com currently covers insider trading research in 4 major stocks markets include U.S., Hong Kong, Mainland China, and Singapore. To view its research reports on a complimentary trial basis and take advantage of its other services, go to http://www.insiderslab.com for North America readers and http://www.insiders.hk for Asia readers.
Important Disclaimer:
Insiderslab.com is not a registered investment advisor and nothing contained in any materials should be construed as a recommendation to buy or sell any securities. Insiders.hk and Insiderslab.com have not been compensated by any of the above-mentioned companies. All calculated numbers or statistics are based on best effort. You hereby acknowledge that any reliance upon any Materials in this press release shall be at your sole risk. Please read our report and visit our Web sites, http://www.insiders.hk and http://www.insiderslab.com , for complete risks and disclosures.
Insider Filing Source Reference:
All observations are based on public information released by U.S. Securities and Exchange Commission.
CONTACT:
Insiders.hk, Insiderslab.com
info@insiderslab.com
Support@insiders.hk
Tel: +1-778-2976120
-
Himfr Analyzes Price Trends in China's Car Market
BEIJING, Sept. 3 /PRNewswire-Asia/ -- Himfr.com, one of China's leading B2B search platforms with more than 30 B2B industry websites to its name, analyzes China's car market.
The price of passenger vehicles in the first half of 2010 has mainly dropped. After March, prices saw their fourth month of consecutive declines. June's price was 3% lower than early in the year. In the second half of the year, inventory pressure will increase and off-season promotion will take effect, creating further price declines in the auto market.
According to statistics, there will be large numbers of new vehicles in the third quarter with an average of three new cars going on the market every week. There will be new offerings from Volkswagen, Shanghai Volkswagen, Guangzhou Honda, Dongfeng Nissan, BYD, Geely and other automobile manufacturers.
Judging from the market situation, the new models going on the market are aggravating the contradiction between supply and demand. There has however, been increased support of the automobile market in China to foster consumer growth, stability and continuity. Furthermore, subsidies for new energy vehicles will have strong support and market demand.
New cars listing on the market not only aggravate the market competition, but also increase diffused consumer choice.
As the fourth quarter approaches, due to stock pressures and receivables consideration, manufacturers will make official price adjustments. At the same time, in order to finish annual sales targets, dealers will likely increase the discount rate to stimulate demand.
About Himfr.com
Himfr.com is a promising e-commerce company and a leading vertical search engine company in China. Himfr.com offers a variety of high quality products such as high shear mixers (http://www.himfr.com/buy-high_shear_mixer ), teeth whitening trays (http://www.himfr.com/buy-teeth_whitening_tray ), load balancing WAN (http://www.himfr.com/buy-load_balancing_wan ) and more.
For more information, please contact:
www.Himfr.com
Tel: +86-10-6556-9770
Email: my@himfr.com
-
Frbiz Analyzes Cutting Tool Development Trends
BEIJING, Sept. 3 /PRNewswire-Asia/ -- Frbiz.com, one of China's leading B2B search platforms, analyzes cutting tool development trends.
Multifunctional cutting tools and high efficient cutting tools will become the mainstream development trend in the industry. Facing increasing difficulties processing materials, the cutting tool industry must improve technology and research new cutting tool mechanics to create more reasonable cutter structures.
Manufacturing technology levels are affected by the cutter industry, while the influence of the development of manufacturing industry also promotes higher cutting tool industry development.
In the future, the multifunctional cutting tool, high-speed and high-efficient cutting tools will become the mainstream of development.
First, carbide materials and coating applications will increase more. Fine particle, super-fine cemented carbide material is the development direction, with nano filters and new structures. Coating materials will greatly improve performance of cutting tools as physical coating applications continue to increase.
Second, new cutting tool applications will increase, with ceramics, metal ceramics, silicon nitride ceramics, PCBN, PCD and so on using cutting tool materials to further enhance their toughness.
Third, cutting technology is experiencing a period of rapid development. High-speed cutting, hard turning and dry cutting continue rapid development, with application scope expanding rapidly.
Fourth, cutting tool research and development is becoming more targeted and specific. Research and development no longer follows common brands and common structures. Facing complex applications and processing conditions, research and development has become stronger.
Fifth, the role of cutting tool manufacturers has changed. From the simple tool manufacturing, the role has extended to new cutting technology development and the corresponding technology and solutions development, to provide users with comprehensive technical support and services.
Sixth, informatization has improved the industry, with manufacturers both cooperating and creating fierce market competition.
About Frbiz.com
Frbiz.com is a promising e-commerce company and a leading vertical search engine company in China. Frbiz.com offers a variety of high quality products (http://www.frbiz.com/products ) such as copper vessel sinks (http://www.frbiz.com/q-copper_vessel_sink ), copper vessel sinks (http://www.frbiz.com/q-copper_vessel_sinks ), sanyo projector lamps (http://www.frbiz.com/q-sanyo_projector_lamps ) and more.
For more information, please contact:
www.frbiz.com
Tel: +86-10-6556-9770
Email: my@frbiz.com
|
